Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration
Michiko Horiguchi, Yuki Oiso, Hitomi Sakai, et al.
Journal of Controlled Release (2015) Vol. 213, pp. 112-119
Closed Access | Times Cited: 25

Showing 25 citing articles:

Mechanisms coupling the mTOR pathway to chronic obstructive pulmonary disease (COPD) pathogenesis
Ankita Goyal, Vishal Chopra, Kranti Garg, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access | Times Cited: 2
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
Ji Young Yhee, Jintaek Im, Richard Nho
Journal of Clinical Medicine (2016) Vol. 5, Iss. 9, pp. 82-82
Open Access | Times Cited: 108
Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
Yanhui Liu, Haobo Kong, Heping Cai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
MicroRNA-181c inhibits cigarette smoke–induced chronic obstructive pulmonary disease by regulating CCN1 expression
Yong Du, Yi Ding, Xuru Chen, et al.
Respiratory Research (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 55
<p>Construction of Potential miRNA–mRNA Regulatory Network in COPD Plasma by Bioinformatics Analysis</p>
Mengchan Zhu, Maosong Ye, Jian Wang, et al.
International Journal of COPD (2020) Vol. Volume 15, pp. 2135-2145
Open Access | Times Cited: 43
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis
Mario Cazzola, Clive P. Page, Paola Rogliani, et al.
Drugs (2025)
Open Access
PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapy
Sharif Moradi, Esmaeil Jarrahi, Ali Ahmadi, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 5, pp. 505-518
Closed Access | Times Cited: 22
PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort
Kenji Sawa, Yasuhiro Koh, Tomoya Kawaguchi, et al.
Lung Cancer (2017) Vol. 112, pp. 96-101
Closed Access | Times Cited: 22
Pulmonary administration of 1,25-dihydroxyvitamin D3 to the lungs induces alveolar regeneration in a mouse model of chronic obstructive pulmonary disease
Michiko Horiguchi, Mai Hirokawa, Kaori Abe, et al.
Journal of Controlled Release (2016) Vol. 233, pp. 191-197
Closed Access | Times Cited: 20
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema
Irene Coppolino, Paolo Ruggeri, Francesco Nucera, et al.
COPD Journal of Chronic Obstructive Pulmonary Disease (2018) Vol. 15, Iss. 5, pp. 536-556
Open Access | Times Cited: 19
Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma
Ridhima Wadhwa, Taru Aggarwal, Noopur Thapliyal, et al.
Elsevier eBooks (2019), pp. 59-73
Closed Access | Times Cited: 18
Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology
Zhen Chen, Pan Chen, Hao Wu, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1644-1644
Open Access | Times Cited: 18
PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy
Flora Pirozzi, Kai Ren, Alessandra Murabito, et al.
Current Medicinal Chemistry (2018) Vol. 26, Iss. 16, pp. 2791-2800
Closed Access | Times Cited: 18
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption
Jiacheng Sun, Guoping Cai, Jinlong Shen, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1275-1288
Open Access | Times Cited: 4
Effects of Tibetan medicine Longdan zhike tablet on chronic obstructive pulmonary disease through MAPK pathway
Yulin Feng, Pengfei Qin, Rong Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118082-118082
Closed Access | Times Cited: 1
Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Alfonso Carleo, Joanna Chorostowska‐Wynimko, Thomas Koeck, et al.
International Journal of COPD (2017) Vol. Volume 12, pp. 829-837
Open Access | Times Cited: 12
A Case for Phosphoinositide 3-Kinase–Targeted Therapy for Infectious Disease
Folayemi Adefemi, David A. Fruman, Aaron J. Marshall
The Journal of Immunology (2020) Vol. 205, Iss. 12, pp. 3237-3245
Open Access | Times Cited: 7
p55PIK deficiency and its NH2-terminal derivative inhibit inflammation and emphysema in COPD mouse model
Ting Wang, Xiaohui Du, Zhihua Wang, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 321, Iss. 1, pp. L159-L173
Closed Access | Times Cited: 7
Characterizing Pharmacokinetic–Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L. McLeod, Malgorzata A. Gil, Dapeng Chen, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 369, Iss. 2, pp. 223-233
Open Access | Times Cited: 5
Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease–Like Pathophysiology
Hitomi Sakai, Michiko Horiguchi, Tomomi Akita, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 361, Iss. 3, pp. 501-505
Open Access | Times Cited: 4
Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema
Chihiro Ozawa, Michiko Horiguchi, Tomomi Akita, et al.
Biological and Pharmaceutical Bulletin (2016) Vol. 39, Iss. 5, pp. 778-785
Open Access | Times Cited: 3
Novel Targets for Chronic Inflammatory Diseases: Focus On Therapeutic Drugs and Natural Compounds, volume II

Frontiers research topics (2024)
Open Access
Stem Cells/Lung Organoids and Lung Rejuvenation in the Treatment of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema
Francesco Nucera, Philip M. Hansbro, Lauren H. Fairley, et al.
Elsevier eBooks (2024), pp. 94-114
Closed Access
Induction of mucosal immunity by pulmonary administration of a cell-targeting nanoparticle
Tomoaki Kurosaki, Yuki Katafuchi, Junya Hashizume, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1585-1593
Open Access | Times Cited: 3
Am80-Encapsulated Lipid Nanoparticles, Developed with the Aim of Achieving Alveolar Regeneration, Have an Improvement Effect on Pulmonary Emphysema
Tomomi Akita, Yuki Morita, Takehiro Kawai, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 37-37
Open Access | Times Cited: 2
Page 1

Scroll to top